Natera Company
Natera is a global leader in providing cell-free DNA testing across multiple clinical areas including women's health, organ health, and oncology. Natera offers a full menu of high-quality genetic tests to support the entire spectrum of women’s health needs—from planning a family and prenatal testing to hereditary cancer screening.
Technology:
Pregnancy biomarkers, Biomarkers of Female Cancers
Industry:
Longevity
Headquarters:
San Carlos, California, United States
Founded Date:
01-01-2004
Employees Number:
1001-5000
Funding Status:
IPO
Investors Number:
15
Total Funding:
$809,150,000
Estimated Revenue:
$50M to $100M
Last Funding Date:
2022-11-15
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership